UK markets closed

Q32 Bio Inc. (0T6G.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
25.90-2.35 (-8.32%)
At close: 05:09PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-14.63%
S&P500 52-week change 323.10%
52-week high 326.66
52-week low 30.46
50-day moving average 30.66
200-day moving average 30.88

Share statistics

Avg vol (3-month) 32.63k
Avg vol (10-day) 33.86k
Shares outstanding 537.31M
Implied shares outstanding 6N/A
Float 84.87M
% held by insiders 19.25%
% held by institutions 167.81%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.055556:1
Last split date 326 Mar 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)176.03%

Management effectiveness

Return on assets (ttm)-55.42%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)-6.65M
Revenue per share (ttm)-0.92
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -47.76M
Net income avi to common (ttm)-53.74M
Diluted EPS (ttm)-0.05
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)25.62M
Total cash per share (mrq)2.15
Total debt (mrq)50.84M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.04
Book value per share (mrq)-24.48

Cash flow statement

Operating cash flow (ttm)-18.68M
Levered free cash flow (ttm)-40.9M